(Q43516115)

English

Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR). (English)

1 reference

Europe PubMed Central

24 November 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

F Maindrault-Goebel

1

1 reference

Europe PubMed Central

24 November 2017

A de Gramont

2

1 reference

Europe PubMed Central

24 November 2017

C Louvet

3

1 reference

Europe PubMed Central

24 November 2017

T André

4

1 reference

Europe PubMed Central

24 November 2017

E Carola

5

1 reference

Europe PubMed Central

24 November 2017

V Gilles

6

1 reference

Europe PubMed Central

24 November 2017

J P Lotz

7

1 reference

Europe PubMed Central

24 November 2017

C Tournigand

8

1 reference

Europe PubMed Central

24 November 2017

M Mabro

9

1 reference

Europe PubMed Central

24 November 2017

J L Molitor

10

1 reference

Europe PubMed Central

24 November 2017

P Artru

11

1 reference

Europe PubMed Central

24 November 2017

V Izrael

12

1 reference

Europe PubMed Central

24 November 2017

M Krulik

13

1 reference

Europe PubMed Central

24 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2000

1 reference

Europe PubMed Central

24 November 2017

Annals of Oncology

1 reference

Europe PubMed Central

24 November 2017

11

1 reference

Europe PubMed Central

24 November 2017

11

1 reference

Europe PubMed Central

24 November 2017

1477-1483

1 reference

Europe PubMed Central

24 November 2017

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

The calculation of received dose intensity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of dose intensity in conservative treatment of anal canal carcinoma. Report of 35 cases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of information on drug resistance on protocol design

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Fluorouracil dose intensity increase in 5-fluorouracil and leucovorin combination: results of a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose intensity in the treatment of diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

What determines actual chemotherapy dose intensity?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1026520812351

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1026520812351

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43516115&oldid=1627430002"